Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Grant | Alive

About Helios Biotechnology & Pharmaceuticals

Helios Biotechnology & Pharmaceuticals has developed a novel technology that may be useful in the treatment of certain cancers and auto-immune diseases.

Helios Biotechnology & Pharmaceuticals Headquarters Location


United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Helios Biotechnology & Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Helios Biotechnology & Pharmaceuticals is included in 1 Expert Collection, including Cancer.



4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

  • What is Helios Biotechnology & Pharmaceuticals's latest funding round?

    Helios Biotechnology & Pharmaceuticals's latest funding round is Grant.

  • Who are the investors of Helios Biotechnology & Pharmaceuticals?

    Investors of Helios Biotechnology & Pharmaceuticals include Invent Penn State.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.